September 28 | 11:00 AM ET
This presentation will provide an overview of sodium-glucose cotransporter 2 (SGLT2) inhibitors and their role in the management of chronic kidney disease. Attendees will learn about the mechanism of action, clinical benefits, safety considerations, and monitoring requirements associated with these medications. The session will also highlight current guideline recommendations.
.
Presented by:
CE Credit: 1.00 | Post-Webinar Survey Required
Open to all dialysis professionals.
..
19 Mantua RoadMount Royal, New Jersey 08061
Phone: 215-320-4655Email: admin@renalhealthcare.org
JoinEducation StationSponsorship Opportunities
Privacy Policy & Terms